ClinicalTrials.govpublic full text
Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck
neoplasms, head and neck, vegfr2, xl880, foretinib, squamous cell cancer of the head and neck, met, gsk1363089, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842170
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.